Yongan Futures(SH:600927)2024-08-31 08:00Investment Rating - The report maintains an "Outperform" rating for Yongan Futures, indicating expected growth above the market benchmark over the next 12-18 months [18]. Core Insights - Yongan Futures reported a significant improvement in Q2 net profit, with a revenue of RMB 12.11 billion for H1 2024, a year-on-year increase of 1.2%, and a net profit attributable to shareholders of RMB 0.31 billion, down 25.4% year-on-year [15][18]. - The company experienced a notable recovery in Q2, with revenue reaching RMB 7.77 billion, up 17.7% year-on-year, and net profit of RMB 0.23 billion, up 12.7% compared to a drastic decline of 62.6% in Q1 [15][18]. - Investment income showed a significant increase, with total investment profit and fair value changes amounting to RMB 0.43 billion, a 70% increase year-on-year [15][18]. Financial Performance Summary - For H1 2024, the company's revenue from futures brokerage was RMB 0.49 billion, down 21% year-on-year, while net transaction fee income was RMB 0.20 billion, down 36% [16]. - The risk management business saw a revenue of RMB 11.3 billion, reflecting a 1.5% year-on-year increase, with significant growth in OTC derivatives and market-making activities [16][17]. - The overseas business reported a revenue of RMB 0.3 billion, a substantial increase of 68% year-on-year, driven by a 75% rise in overseas futures brokerage trading volume [17]. Business Segment Analysis - The asset management segment rebounded with revenue of RMB 0.11 billion, up 74% year-on-year, while fund sales revenue decreased by 24% to RMB 0.24 billion [17]. - The futures brokerage segment faced challenges with a trading volume decline of 13.5% year-on-year, leading to a decrease in client equity by 24.7% from the beginning of the year [16][18]. - The report highlights the company's strong position in the domestic futures industry, projecting EPS for 2024 and 2025 at RMB 0.46 and RMB 0.49 respectively, with a target price of RMB 13.42 based on a 29x PE ratio for 2024 [18].